Implementable assay for monitoring minimum residual disease after radical treatment for colorectal cancer
Takafumi Nakano(Jikei University School of Medicine), Koshi Mimori(Kyushu University Beppu Hospital)
Cited by 3
Related Papers
Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers
|British Journal of Cancer|2013|288
Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway
|Carcinogenesis|2012|174
Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer
|British Journal of Cancer|2015|63